180 related articles for article (PubMed ID: 22894570)
1. Enhanced control of in vivo bone formation with surface functionalized alginate microbeads incorporating heparin and human bone morphogenetic protein-2.
Abbah SA; Liu J; Goh JC; Wong HK
Tissue Eng Part A; 2013 Feb; 19(3-4):350-9. PubMed ID: 22894570
[TBL] [Abstract][Full Text] [Related]
2. In vivo bioactivity of rhBMP-2 delivered with novel polyelectrolyte complexation shells assembled on an alginate microbead core template.
Abbah SA; Liu J; Lam RW; Goh JC; Wong HK
J Control Release; 2012 Sep; 162(2):364-72. PubMed ID: 22846985
[TBL] [Abstract][Full Text] [Related]
3. Novel Protamine-Based Polyelectrolyte Carrier Enhances Low-Dose rhBMP-2 in Posterolateral Spinal Fusion.
Hu T; Abbah SA; Wang M; Toh SY; Lam RW; Naidu M; Bhakta G; Cool SM; Bhakoo K; Li J; Goh JC; Wong HK
Spine (Phila Pa 1976); 2015 May; 40(9):613-21. PubMed ID: 25705961
[TBL] [Abstract][Full Text] [Related]
4. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft.
Krishnan L; Priddy LB; Esancy C; Li MT; Stevens HY; Jiang X; Tran L; Rowe DW; Guldberg RE
Clin Orthop Relat Res; 2015 Sep; 473(9):2885-97. PubMed ID: 25917422
[TBL] [Abstract][Full Text] [Related]
5. Development of collagen-hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering.
Quinlan E; López-Noriega A; Thompson E; Kelly HM; Cryan SA; O'Brien FJ
J Control Release; 2015 Jan; 198():71-9. PubMed ID: 25481441
[TBL] [Abstract][Full Text] [Related]
6. Minimizing the severity of rhBMP-2-induced inflammation and heterotopic ossification with a polyelectrolyte carrier incorporating heparin on microbead templates.
Wang M; Abbah SA; Hu T; Toh SY; Lam RW; Goh JC; Wong HK
Spine (Phila Pa 1976); 2013 Aug; 38(17):1452-8. PubMed ID: 23380826
[TBL] [Abstract][Full Text] [Related]
7. Long-term controlled delivery of rhBMP-2 from collagen-hydroxyapatite scaffolds for superior bone tissue regeneration.
Quinlan E; Thompson EM; Matsiko A; O'Brien FJ; López-Noriega A
J Control Release; 2015 Jun; 207():112-9. PubMed ID: 25817394
[TBL] [Abstract][Full Text] [Related]
8. Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold.
Zhao L; Tang M; Weir MD; Detamore MS; Xu HH
Tissue Eng Part A; 2011 Apr; 17(7-8):969-79. PubMed ID: 21091340
[TBL] [Abstract][Full Text] [Related]
9. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels.
Jeon O; Powell C; Solorio LD; Krebs MD; Alsberg E
J Control Release; 2011 Sep; 154(3):258-66. PubMed ID: 21745508
[TBL] [Abstract][Full Text] [Related]
10. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
[TBL] [Abstract][Full Text] [Related]
11. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
[TBL] [Abstract][Full Text] [Related]
12. Segmental bone regeneration using rhBMP-2-loaded collagen/chitosan microspheres composite scaffold in a rabbit model.
Hou J; Wang J; Cao L; Qian X; Xing W; Lu J; Liu C
Biomed Mater; 2012 Jun; 7(3):035002. PubMed ID: 22358865
[TBL] [Abstract][Full Text] [Related]
13. Localization and promotion of recombinant human bone morphogenetic protein-2 bioactivity on extracellular matrix mimetic chondroitin sulfate-functionalized calcium phosphate cement scaffolds.
Huang B; Wu Z; Ding S; Yuan Y; Liu C
Acta Biomater; 2018 Apr; 71():184-199. PubMed ID: 29355717
[TBL] [Abstract][Full Text] [Related]
14. Controlled delivery of low-dose bone morphogenetic protein-2 using heparin-conjugated fibrin in the posterolateral lumbar fusion of rabbits.
Koo KH; Lee JM; Ahn JM; Kim BS; La WG; Kim CS; Im GI
Artif Organs; 2013 May; 37(5):487-94. PubMed ID: 23461810
[TBL] [Abstract][Full Text] [Related]
15. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
[TBL] [Abstract][Full Text] [Related]
16. Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties.
Raina DB; Larsson D; Mrkonjic F; Isaksson H; Kumar A; Lidgren L; Tägil M
J Control Release; 2018 Feb; 272():83-96. PubMed ID: 29329716
[TBL] [Abstract][Full Text] [Related]
17. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
[TBL] [Abstract][Full Text] [Related]
18. Repair of rat calvarial bone defects by controlled release of rhBMP-2 from an injectable bone regeneration composite.
Tan R; She Z; Wang M; Yu X; Jin H; Feng Q
J Tissue Eng Regen Med; 2012 Aug; 6(8):614-21. PubMed ID: 21916016
[TBL] [Abstract][Full Text] [Related]
19. Oxidized alginate hydrogels for bone morphogenetic protein-2 delivery in long bone defects.
Priddy LB; Chaudhuri O; Stevens HY; Krishnan L; Uhrig BA; Willett NJ; Guldberg RE
Acta Biomater; 2014 Oct; 10(10):4390-9. PubMed ID: 24954001
[TBL] [Abstract][Full Text] [Related]
20. Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion.
Majid K; Tseng MD; Baker KC; Reyes-Trocchia A; Herkowitz HN
Spine J; 2011 Jun; 11(6):560-7. PubMed ID: 20097616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
